Zacks Adds Caesars Entertainment, Cartesian Therapeutics, and Insperity to Strong Sell List

Analyst
โดย Zacks Investment Research·Read original
Summary · why it matters

Zacks Investment Research added three stocks to its Zacks Rank #5 (Strong Sell) List today. Caesars Entertainment saw its current-year earnings consensus estimate revised 104.2% downward over the last 60 days. Cartesian Therapeutics had its estimate cut by 7%, while Insperity's estimate was revised 11.6% lower over the same period.

Impact on stocks 3

Consumer Discretionary · 1 stocks
Industrials · 1 stocks
Insperity Inc
NSP
▼ NegativeCapitalrelevance

Earnings consensus estimate revised 11.6% lower over 60 days

Biotech & Genomic Medicine · 1 stocks